Article
Interpretation of copy number alterations identified through clinical microarray-comparative genomic hybridization.
Clinics in laboratory medicine - 1 Dec 2011
Pyatt Robert E, Astbury Caroline
Abstract excerpt
Many copy number alterations (CNA) currently interpreted as variants of unknown significance (VUS) will ultimately be determined to be benign; however, their classification requires a more extensive characterization of the human genome than currently exists. There is no definitive set of rules or level of evidence required to define a CNA as benign. The information needed to accurately assess the pathogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
